employee from 01.01.2023 until now
Regional Clinical Specialized Neuropsychiatric Hospital No. 1 (Clinical Department of the first Psychotic Episode, Head of the Clinical Department)
employee
Russian Federation
VAK Russia 3.1.24
CSCSTI 76.29
The purpose of this study is to conduct a narrative analysis of the scientific research literature aimed at studying the duration of untreated psychosis as a prognostic factor for the effectiveness of therapy and long-term prognosis of schizophrenic spectrum disorders. Materials and methods: The review is based on a systematic search in research databases for 2019-2025 with an analysis of more than 189 original papers, meta-analyses and systematic reviews. Results and discussion: a stable association has been established between a prolonged period of untreated psychosis and the severity of negative symptoms, cognitive deficits, decreased social functioning, and high suicidal risk. The introduction of early intervention programs that shorten this interval is associated with a good response to therapy and a favorable course of the disease. Conclusion. The duration of untreated psychosis is a significant factor in the prognosis of the disease, which justifies the need to reorganize psychiatric care towards preventive models. The implementation of comprehensive measures, including early detection, education, and optimization of patient routing, can mitigate negative effects and improve outcomes.
duration of untreated psychosis, schizophrenia, early intervention, schizophrenic spectrum disorders, first psychotic episode
1. Catalan A., Salazar de Pablo G., Aymerich C., et al. ” Short” Versus “Long” Duration of Untreated Psychosis in People with First-Episode Psychosis: A Systematic Review and Meta-Analysis of Baseline Status and Follow-Up Outcomes //Schizophrenia bulletin. – 2025. – T. 51. – №. 5. – S. 1206-1230.
2. Howes O.D., Whitehurst T., Shatalina E., et al. The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis //World Psychiatry. – 2021. – T. 20. – №. 1. – S. 75-95.
3. Fusar-Poli P., McGorry P.D., Kane J.M. Improving outcomes of first‐episode psychosis: an overview //World psychiatry. – 2017. – T. 16. – №. 3. – S. 251-265.
4. Marshall M., Lewis S., Lockwood A., et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review //Archives of general psychiatry. – 2005. – T. 62. – №. 9. – S. 975-983.
5. Perkins D.O., Gu H., Boteva K., Lieberman J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis //American journal of psychiatry. – 2005. – T. 162. – №. 10. – S. 1785-1804.
6. Salazar de Pablo G., Aymerich C., Guinart D., et al. What is the duration of untreated psychosis worldwide? A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies //Psychological medicine. – 2024. – T. 54. – №. 4. – S. 652-662.
7. Drake R.J., Husain N., Marshall M., et al. Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study //The Lancet Psychiatry. – 2020. – T. 7. – №. 7. – S. 602-610.
8. Boonstra N., Klaassen R., Sytema S., et al. Duration of untreated psychosis and negative symptoms—a systematic review and meta-analysis of individual patient data //Schizophrenia research. – 2012. – T. 142. – №. 1-3. – S. 12-19.
9. Zayceva, Yu. S. Znachenie pokazatelya "dlitel'nost' nelechennogo psihoza" pri pervom psihoticheskom epizode shizofrenii / Social'naya i klinicheskaya psihiatriya. – 2007. – T. 17, № 1. – S. 72-79.
10. Penttilä M., Jaaskelainen E., Hirvonen N., et al. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis //The British Journal of Psychiatry. – 2014. – T. 205. – №. 2. – S. 88-94.
11. Correll C.U., Galling B., Pawar A., et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression //JAMA psychiatry. – 2018. – T. 75. – №. 6. – S. 555-565.
12. Kane J.M., Robinson D.G., Schooler N.R., et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program //American Journal of Psychiatry. – 2016. – T. 173. – №. 4. – S. 362-372.
13. Maximo J.O., Nelson E.A., Armstrong W.P., et al. Duration of untreated psychosis correlates with brain connectivity and morphology in medication-naive patients with first-episode psychosis //Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. – 2020. – T. 5. – №. 2. – S. 231-238.
14. Briend F., Nelson E.A., Maximo O., et al. Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis //Translational psychiatry. – 2020. – T. 10. – №. 1. – S. 137.
15. Malla A.K., Bodnar M., Joober R., Lepage M. Duration of untreated psychosis is associated with orbital–frontal grey matter volume reductions in first episode psychosis //Schizophrenia research. – 2011. – T. 125. – №. 1. – S. 13-20.
16. Allott K. et al. Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis //Psychological medicine. – 2018. – T. 48. – №. 10. – S. 1592-1607.
17. Chang W.C., Tang J.Y., Hui C.L., et al. Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study //Psychological Medicine. – 2013. – T. 43. – №. 9. – S. 1883-1893.
18. Hafner H., Maurer K., Trendler G., et al. The early course of schizophrenia and depression //European Archives of Psychiatry and Clinical Neuroscience. – 2005. – T. 255. – №. 3. – S. 167-173.
19. Singh S.P., Cooper J.E., Fisher H.L., et al. Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS) //Schizophrenia research. – 2005. – T. 80. – №. 1. – S. 117-130.
20. Iyer S.N., Boekestyn L., Cassidy C.M., et al. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories //Psychological medicine. – 2008. – T. 38. – №. 8. – S. 1147-1156.
21. Ucok A., Polat A., Cakir S., et al. One year outcome in first episode schizophrenia: Predictors of relapse //European archives of psychiatry and clinical neuroscience. – 2006. – T. 256. – №. 1. – S. 37-43.
22. McGorry P., Nelson B., Amminger G.P., et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions //The Journal of clinical psychiatry. – 2009. – T. 70. – №. 9. – S. 9320.
23. Kane J. M. et al. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design //The Journal of clinical psychiatry. – 2015. – T. 76. – №. 3. – S. 16590.
24. Forsyth J. K., Bearden C. E. Rethinking the first episode of schizophrenia: identifying convergent mechanisms during development and moving toward prediction //American Journal of Psychiatry. – 2023. – T. 180. – №. 11. – S. 792-804.
25. Morgan C., Gayer-Anderson C. Childhood adversities and psychosis: evidence, challenges, implications //World psychiatry. – 2016. – T. 15. – №. 2. – S. 93-102.
26. Leposavić I., Dukanac V. Neuropsychological disorders in patients with schizophrenia and depression //Vojnosanitetski pregled. – 2025. – T. 82. – №. 04.
27. Maj M. et al. The clinical characterization of the patient with primary psychosis aimed at personalization of management //World Psychiatry. – 2021. – T. 20. – №. 1. – S. 4-33.
28. Becker H. E. et al. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? //Psychological medicine. – 2010. – T. 40. – №. 10. – S. 1599-1606.
29. Clarke M., Whitty P., Browne S., et al. Suicidality in first episode psychosis //Schizophrenia research. – 2006. – T. 86. – №. 1-3. – S. 221-225.
30. Xu Y. E. et al. Suicidal behavior across a broad range of psychiatric disorders //Molecular psychiatry. – 2023. – T. 28. – №. 7. – S. 2764-2810.
31. Hu M. et al. Structural and diffusion MRI based schizophrenia classification using 2D pretrained and 3D naive Convolutional Neural Networks //Schizophrenia research. – 2022. – T. 243. – S. 330-341.
32. De Pablo G. S. et al. What is the duration of untreated psychosis worldwide?–A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies //Psychological medicine. – 2024. – T. 54. – №. 4. – S. 652-662.
33. Chinarev V. A., Malinina E. V. Vliyanie dlitel'nosti nelechenogo psihoza na veroyatnost' nedobrovol'noy gospitalizacii s pervym psihoticheskim epizodom //Medicinskiy vestnik Yuga Rossii. – 2025. – T. 16. – №. 2. – S. 65-74.
34. Chinarev V. A., Malinina E. V., Obuhova M. D. Nelechennyy psihoz v anamneze: vliyanie na prognoz paranoidnoy shizofrenii. Klinicheskiy sluchay //PSIHIATRIYa. – 2025. – T. 22. – №. 6. – S. 72-81.
35. González-Rodríguez A. et al. Schizophrenia: A review of social risk factors that affect women //Behavioral Sciences. – 2023. – T. 13. – №. 7. – S. 581.
36. Inns M. et al. Can We Detect the Undetected? Comparing the Prodromes of Individuals with First Episode Psychosis Detected and Undetected by Clinical High-Risk for Psychosis Services: An Electronic Health Record Study //Schizophrenia Bulletin. – 2025. – S. sbaf201.
37. Myaba J., Mwale C. M., Jumbe V. C. Clinical predictors of duration of untreated psychosis: exploring psychosocial and clinical predictors of duration of untreated psychosis in first-episode psychotic patients in Mzuzu, Malawi //Malawi Medical Journal. – 2021. – T. 33. – №. Postgraduate Supplementary Iss. – S. 23.
38. Youn S. et al. Systematic review and meta-analysis: rates of violence during first-episode psychosis (FEP) //Schizophrenia bulletin. – 2024. – T. 50. – №. 4. – S. 757-770.
39. Van Os J., Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population //World Psychiatry. – 2016. – T. 15. – №. 2. – S. 118-124.
40. Leeson V.C., Barnes T.R., Harrison M., et al. The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome //Schizophrenia bulletin. – 2010. – T. 36. – №. 2. – S. 400-409.
41. Pruessner M. et al. Gender differences in childhood trauma in first episode psychosis: Association with symptom severity over two years //Schizophrenia research. – 2019. – T. 205. – S. 30-37.
42. Qiu X. et al. Gender differences in the influencing factors of violent behavior in patients with schizophrenia //Middle East Current Psychiatry. – 2025. – T. 32. – №. 1. – S. 5.
43. Verdaguer-Rodríguez M. et al. Benefits of Water Aerobic Exercise on Mental Health Outcomes in Severe Mental Illness: The Effects of Sex //Women. – 2025. – T. 5. – №. 1. – S. 8.
44. Moniem I., Kafetzopoulos V. Sex differences in schizophrenia: symptomatology, treatment efficacy and adverse effects //Frontiers in Psychiatry. – 2025. – T. 16. – S. 1594334.
45. Lehmann P. Paradigm shift: treatment alternatives to psychiatric drugs, with particular reference to low-and middle-income countries 1 //The Routledge Handbook of International Development, Mental Health and Wellbeing. – Routledge, 2019. – S. 251-269.
46. Patel V., Prince M. Global mental health: a new global health field comes of age //Jama. – 2010. – T. 303. – №. 19. – S. 1976-1977.
47. Kirmayer L. J., Pedersen D. Toward a new architecture for global mental health //Transcultural psychiatry. – 2014. – T. 51. – №. 6. – S. 759-776.
48. McGorry P. D. et al. The Lancet Psychiatry Commission on youth mental health //The Lancet Psychiatry. – 2024. – T. 11. – №. 9. – S. 731-774.
49. DiMatteo M. R., Martin L. R., Haskard-Zolnierek K. B. Health behavior change and treatment adherence: Evidence-based guidelines for improving healthcare. – Oxford University Press, 2025.
50. Singh B. et al. Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews //British journal of sports medicine. – 2023. – T. 57. – №. 18. – S. 1203-1209.
51. Chicherin L. P., Schepin V. O. Psihiatricheskaya pomosch' naseleniyu rossii: baza, kadry, normativnaya i organizacionno-metodicheskaya harakteristika // Problemy social'noy gigieny, zdravoohraneniya i istorii mediciny. – 2025. – T. 33. – №. 1. – S. 105-111.
52. Jonas K.G., Fochtmann L.J., Perlman G., et al. Lead-time bias confounds association between duration of untreated psychosis and illness course in schizophrenia //American Journal of Psychiatry. – 2020. – T. 177. – №. 4. – S. 327-334.
